The role of GPs in increasing compliance to colorectal cancer screening: a randomised controlled trial (Italy)

被引:54
作者
Federici, A
Rossi, PG
Bartolozzi, F
Farchi, S
Borgia, P
Guastcchi, G
机构
[1] Agcy Publ Hlth, I-00198 Rome, Italy
[2] Univ Hosp, Rome, Italy
关键词
colorectal cancer; compliance; general practitioners; oncological screening; randomised controlled trial;
D O I
10.1007/s10552-005-0380-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims To assess the effect of the provider (GPs versus hospital) on the compliance in returning the faecal occult blood test. To analyse the characteristics of the GP associated with high compliance among his beneficiaries. Methods A questionnaire about screening attitudes was mailed to the 1192 GPs working in 13 districts of the Lazio region. We asked the GPs to participate in a randomised trial, we sampled 130 GPs and about 1/10 of the GPs' 50-75 year old beneficiaries (n = 3657) were invited to be screened at the GP office and 1/10 (3675) at the nearest gastroenterology centre. Results 58.5% of the GPs completed the questionnaire and 22.7% agreed to participate in the trial. The compliance in the GP arm was 50%, in the hospital arm 16% (RR 3.4; 95% CI: 3.13-3.70). There was a high variability in the compliance obtained by the GPs. GPs with more than 25 patients visited/day and those incorrectly recommended screening of colorectal cancer obtained a lower compliance (OR 0.74, 95% CI: 0.57-0.95 and OR 0.76, 95% CI: 0.59-0.97, respectively). Conclusions The involvement of GPs in colorectal cancer screening can be very effective to enhance the compliance, but the effectiveness is dependent on their willingness to be involved.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 33 条
[1]  
[Anonymous], 2000, HEALTH TECHNOL ASSES
[2]   A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer [J].
Cole, SR ;
Young, GP ;
Esterman, A ;
Cadd, B ;
Morcom, J .
JOURNAL OF MEDICAL SCREENING, 2003, 10 (03) :117-122
[3]   Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner [J].
Cole, SR ;
Young, GP ;
Byrne, D ;
Guy, JR ;
Morcom, J .
JOURNAL OF MEDICAL SCREENING, 2002, 9 (04) :147-152
[4]  
COLE SR, 2001, MED J AUSTRALIA, V20, P195
[5]  
*EP DAT FREEW, 2001, EP SOFTW REL V2 1
[6]   The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial [J].
Federici, A ;
Rossi, PG ;
Borgia, P ;
Bartolozzi, F ;
Farchi, S ;
Gausticchi, G .
JOURNAL OF MEDICAL SCREENING, 2005, 12 (02) :83-88
[7]   Survey on colorectal cancer screening knowledge, attitudes, and practices of general practice physicians in Lazio, Italy [J].
Federici, A ;
Rossi, PG ;
Bartolozzi, F ;
Farchi, S ;
Borgia, P ;
Guastcchi, G .
PREVENTIVE MEDICINE, 2005, 41 (01) :30-35
[8]  
Fernandez J L, 1999, Acta Gastroenterol Latinoam, V29, P73
[9]  
Friedman LC, 2001, J CANCER EDUC, V16, P85
[10]   Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results [J].
Grazzini, G ;
Castiglione, G ;
Ciabattoni, C ;
Franceschini, F ;
Giorgi, D ;
Gozzi, S ;
Mantellini, P ;
Lopane, P ;
Perco, M ;
Rubeca, T ;
Salvadori, P ;
Visioli, CB ;
Zappa, M .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2004, 13 (01) :19-26